BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8904089)

  • 1. Effect of sub-inhibitory concentrations of clarithromycin and erythromycin on the production of Staphylococcus aureus capsules.
    Ohtomo T; Ohshima Y; Usui Y; Ichiman Y; Yanagisawa N; Yokota E; Shimada J
    J Chemother; 1995 Nov; 7 Suppl 4():9-11. PubMed ID: 8904089
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of macrolides on ultrastructure of Staphylococcus aureus during postantibiotic phase.
    Watanabe T; Kanno M; Tejima E; Orikasa Y
    Drugs Exp Clin Res; 1992; 18(3):81-8. PubMed ID: 1425207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on bacterial biofilm destruction by various antibacterial agents].
    Kozeki S; Miyamoto N; Suzuki K; Hashiba M; Baba S
    Jpn J Antibiot; 1998 Jan; 51 Suppl A():142-5. PubMed ID: 9597510
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular investigation of the postantibiotic effects of clarithromycin and erythromycin on Staphylococcus aureus cells.
    Champney WS; Tober CL
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1324-8. PubMed ID: 10348746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythromycin-resistant Staphylococcus aureus in Denmark.
    Westh H
    APMIS Suppl; 1996; 57():1-37. PubMed ID: 8600946
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimicrobial resistance of Staphylococcus aureus and oral streptococci strains from high-risk endocarditis patients.
    Groppo FC; Castro FM; Pacheco AB; Motta RH; Filho TR; Ramacciato JC; Florio FM; Meechan JG
    Gen Dent; 2005; 53(6):410-3. PubMed ID: 16366048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of four antibiotics in a murine model of necrotizing cutaneous infections caused by toxigenic Streptococcus pyogenes and Staphylococcus aureus.
    Barg N
    J Antimicrob Chemother; 1998 Aug; 42(2):257-60. PubMed ID: 9738847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Loss of erythromycin sensitivity in strains of Staphylococcus aureus].
    López-Yeste ML; Lite Lite J
    Enferm Infecc Microbiol Clin; 1997 May; 15(5):280. PubMed ID: 9376396
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythromycin-induced resistance to clindamycin in Staphylococcus aureus.
    Marr JK; Lim AT; Yamamoto LG
    Hawaii Med J; 2005 Jan; 64(1):6-8. PubMed ID: 15751751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of antibiotics on intracellular bacteria. 2. Effect of antibiotic treatment on Staphylococcus aureus 209P phagocytized by mouse polymorphonuclear leukocytes].
    Kato C; Saito K
    Shigaku; 1985 Feb; 72(5):1096-107. PubMed ID: 3857540
    [No Abstract]   [Full Text] [Related]  

  • 11. Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues.
    Griesgraber G; Kramer MJ; Elliott RL; Nilius AM; Ewing PJ; Raney PM; Bui MH; Flamm RK; Chu DT; Plattner JJ; Or YS
    J Med Chem; 1998 May; 41(10):1660-70. PubMed ID: 9572891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spread of erythromycin-, tetracycline-, and aminoglycoside-resistant genes in methicillin-resistant Staphylococcus aureus clinical isolates in a Kumamoto Hospital.
    Sekiguchi J; Fujino T; Saruta K; Kawano F; Takami J; Miyazaki H; Kuratsuji T; Yoshikura H; Kirikae T
    Jpn J Infect Dis; 2003 Jun; 56(3):133-7. PubMed ID: 12944686
    [No Abstract]   [Full Text] [Related]  

  • 13. Inducible clindamycin resistance in erythromycin-resistant, non-multiresistant, methicillin-resistant Staphylococcus aureus.
    Munckhof WJ; Kleinschmidt SL; Schooneveldt JM
    Pathology; 2004 Aug; 36(4):373-4. PubMed ID: 15370145
    [No Abstract]   [Full Text] [Related]  

  • 14. Macrolide-lincosamide-streptogramin B resistance phenotypes and genotypes among Staphylococcus aureus clinical isolates in Japan.
    Otsuka T; Zaraket H; Takano T; Saito K; Dohmae S; Higuchi W; Yamamoto T
    Clin Microbiol Infect; 2007 Mar; 13(3):325-7. PubMed ID: 17391391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antibacterial activity of 3-keto-6-O-carbamoyl-11,12-cyclic thiocarbamate erythromycin A derivatives.
    Zhu B; Marinelli BA; Abbanat D; Foleno BD; Bush K; Macielag MJ
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3900-4. PubMed ID: 17502142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new macrolide antibiotic, clarithromycin--synthesis, structure-activity relationship and metabolism].
    Adachi T; Morimoto S
    Seikagaku; 1990 Oct; 62(10):1260-3. PubMed ID: 2150202
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic interaction study between midazolam and the macrolide antibiotics, erythromycin, clarithromycin, and the azalide azithromycin.
    Yeates RA; Laufen H; Zimmermann T; Schumacher T
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):577-9. PubMed ID: 9455717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 50S ribosomal subunit synthesis and translation are equivalent targets for erythromycin inhibition in Staphylococcus aureus.
    Champney WS; Burdine R
    Antimicrob Agents Chemother; 1996 May; 40(5):1301-3. PubMed ID: 8723490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the efficacy of josamycin in the treatment of impetigo in children and its in vitro activity on erythromycin resistant Staphylococcus aureus strains.
    Mosca A; Del Prete R; Mazzotta F; Bonifazi E; Miragliotta G
    J Chemother; 1995 Nov; 7 Suppl 4():158-9. PubMed ID: 8904141
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined efficacy of clarithromycin plus cefazolin or vancomycin against Staphylococcus aureus biofilms formed on titanium medical devices.
    Fujimura S; Sato T; Mikami T; Kikuchi T; Gomi K; Watanabe A
    Int J Antimicrob Agents; 2008 Dec; 32(6):481-4. PubMed ID: 18790609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.